# MaaT Pharma

A Lyon-based pioneer in high-diversity microbial ecosystems for oncology; lead drug MaaT013 reached pivotal phase 3 in Europe for acute graft-versus-host disease with an automated GMP plant.

Source: https://en.bioecon.ru/companies/maat-pharma/
Updated: 2026-07-01

- Country: France
- Ticker: EPA:ALMAAT

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | €37.5 million loan from European Investment Bank (EIB) secured in July 2025 | https://www.maatpharma.com/july-28-2025-maat-pharma-secures-e37-5-million-loan-from-european-investment-bank-eib-marking-a-new-step-in-advancing-its-clinical-program-in-hemato-oncology/ |
| Capacity | 9,000 pouches of MaaT013 and 1.3 million capsules of MaaT033 per year | https://www.pharmaceutical-technology.com/projects/maat-pharmas-microbiome-ecosystem-therapies-manufacturing-facility-france/ |
| Regulatory approval | Marketing Authorization Application for Xervyteg (MaaT013) submitted in June 2025; received negative CHMP opinion in May/June 2026; re-examination planned | https://www.maatpharma.com/june-2-2025-maat-pharma-advances-toward-commercialization-and-submits-marketing-authorization-application-to-the-european-medicines-agency-ema-for-xervyteg-maat013-in-acute-graft-versus-ho/, https://www.maatpharma.com/june-26-2026-maat-pharma-announces-plan-to-request-re-examination-following-negative-chmp-opinion-for-maat013-for-the-treatment-of-acute-graft-versus-host-disease/ |
| Production site | cGMP facility in Saint-Quentin-Fallavier, near Lyon, France | https://www.pharmaceutical-technology.com/projects/maat-pharmas-microbiome-ecosystem-therapies-manufacturing-facility-france/ |
| Revenue | €4.5 million in 2025; €0.8 million in Q1 2026 | https://live.euronext.com/en/products/equities/company-news/2026-03-31-maat-pharma-announces-2025-annual-results-and-provides, https://www.maatpharma.com/may-26-2026-maat-pharma-provides-business-update-and-reports-financial-results-for-the-first-quarter-2026/ |

Independent sources: live.euronext.com, pharmaceutical-technology.com

## Technologies

- [Microbiome therapeutics (live biotherapeutic products)](https://en.bioecon.ru/technology/microbiome-therapeutics-lbps/)